U10 Ful Member Application Affiliated with SWOG

SWOG 附属 U10 正式会员申请

基本信息

批准号：
7363698
负责人：
SCOTT M LIPPMAN
金额：
$ 7.16万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-07-26 至 2009-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7363698
关键词：
Adolescent Americas Anus Appendix Award Bladder Blood Body of uterus Bone Marrow Stem Cell Bone Marrow Transplantation Brain Brain Neoplasms Breast Cancer Center Cancer Center Support Grant Cancer Control Research Cancer Hospital Cancer Patient Caring Chest Child Clinic Clinical Colon Combined Modality Therapy Committee Members Complex Comprehensive Cancer Center Cutaneous Melanoma Data Development Developmental Therapeutics Program Diagnostic Diagnostic Services Disorder by Site Elements Endocrine Enrollment Esophagus Eye Faculty Fatigue Female Genetic screening method Genital system Genitourinary system Genus Cola Grant Group Therapy Growth Gynecologic Oncology Gynecology Head Head and neck structure Hodgkin Disease Hospitals Institution Interdisciplinary Study Internal Medicine Joints Kidney Larynx Leadership Liver Lung Lymphoblastic Leukemia Lymphoma Male Genital Organs Malignant Neoplasms Medical Oncologist Medicine Multimodal Imaging Multiple Myeloma Myeloid Leukemia Newly Diagnosed Numbers Nurses Nursing Faculty Ocular orbit Oral cavity Organ Outpatients Ovary Pain Palliative Care Pancreas Paper Pathologist Patient Care Patients Pharmacists Pharyngeal structure Phase Phase III Clinical Trials Population Principal Investigator Prostate Protocols documentation Radiation Radiation Oncologist Radiation Therapist Rectum Rehabilitation therapy Reporting Research Resource Sharing Resources Science Small Intestines Social Workers Southwest Oncology Group Specialist Specimen Standards of Weights and Measures Stomach Structure Surgeon Surveys System Testing Testis Therapeutic Therapeutics Committee Thyroid Gland Translational Research Tumor Biology University of Texas M D Anderson Cancer Center Vertebral column anticancer research base bone cancer care cancer site cancer type gastrointestinal innovation interest leukemia leukemia/lymphoma member multidisciplinary named group news novel strategies programs respiratory sarcoma soft tissue symptom management treatment center urinary

项目摘要

DESCRIPTION (provided by applicant): The UT M. D. Anderson Cancer Center (MDACC) joined the Southwest Oncology Group (SWOG) as a full member in November 2002. This is our first U10 member application. During the past 3 years and entirely prior to becoming a full SWOG member, MDACC averaged 51 accruals to SWOG therapy studies per year. Our SWOG Program will integrate many elements of MDACCs comprehensive multidisciplinary resources, including 16 specialized Care Centers, where most MDACC patients are treated as outpatients in a multidisciplinary, multimodality team approach. MDACC has 895 cancer research faculty, including 536 clinical faculty. In 2001, MDACC cared for 62,600 cancer patients, of whom 16,144 were newly diagnosed and 3,500 were enrolled in therapeutic protocols. The structure for coordinating SWOG studies includes the Principal Investigator, Co-Principal Investigator, Head CRA, SWOG Program Steering Committee, and leaders of each disease-site program (medical oncologists, radiotherapists, surgeons). Every MDACC-SWOG Program disease-site leader is a MDACC department chair sitting on the Executive Council of the Division of Cancer Medicine headed by Dr. Waun Ki Hong, who enthusiastically supports SWOG therapy/accrual activities within MDACC. Substantial MDACC administrative contributions to SWOG in the past 6 years include Chair, Cancer Control Research Committee and member, SWOG Executive Committee/Scientific Advisory Board (Dr. Lippman); Chair, Gastrointestinal Committee (Dr. Abbruzzese); Co-Chair, Brain Committee (Dr. Sawaya); Vice Chair, Lung Developmental Therapeutics Committee (Dr. Herbst); Chair, Testis Subcommittee (Dr. Logothetis); and Vice Chair, Sarcoma (Special Populations) Committee (Dr. Bleyer). At least 21 MDACC faculty are official members of SWOG and contribute actively to several SWOG committees on a regular basis (e.g., the Gastrointestinal, Brain, Lung, H & N, and Sarcoma committees). Dr. EI-Naggar will head the SWOG H&N Tumor Biology and Correlative Science Subcommittee. Dr. P. Pisters is a consultant for the SWOG Sarcoma Specimen Board. At least 11 MDACC faculty provided scientific leadership as Study Coordinators in 17 SWOG-coordinated protocols (including 3 in development) and co-authored 18 SWOG papers (since 2000). MDACC will apply its historical strengths in developing innovative Phase I, II studies within the SWOG setting. Phase III trials are highly complex and difficult for any single institution to conduct alone, and MDACC looks forward to leading some and joining other SWOG efforts to test novel approaches in Phase Ill, standard-of-care-altering trials.

描述（由申请人提供）：UT M. D. Anderson癌症中心（MDACC）于2002年11月加入了西南肿瘤学集团（SWOG）作为正式会员。这是我们的第一个U10成员申请。在过去的3年中，完全是在成为一个完整的Swog成员之前，MDACC平均每年有51名应计wath疗法研究。我们的SWOG计划将整合MDACC的许多元素综合多学科资源，其中包括16个专业护理中心，其中大多数MDACC患者在多学科的多模型团队方法中被视为门诊病人。 MDACC拥有895个癌症研究学院，其中包括536个临床教师。 2001年，MDACC照顾了62,600名癌症患者，其中有16,144例被新诊断出来，3,500名纳入了治疗方案。协调SWOG研究的结构包括首席研究员，联合主管研究员，Head CRA，SWOG计划指导委员会以及每个疾病现场计划的领导者（医学肿瘤学家，放射治疗师，外科医生）。每个MDACC-S-WOG计划疾病现场负责人都是MDACC部门主席，坐在Waun Ki Hong博士领导的癌症医学部执行委员会上，他热情地支持MDACC中的SWOG治疗/应计活动。在过去的6年中，MDACC对SWOG的大量行政贡献包括主席，癌症控制研究委员会和SWOG执行委员会/科学顾问委员会成员（Lippman博士）；胃肠道委员会主席（Abbruzzese博士）；联合主席，大脑委员会（Sawaya博士）；肺发展治疗委员会（Herbst博士）副主席；睾丸小组委员会主席（Logothetis博士）；和肉瘤副主席（特殊人口）委员会（Bleyer博士）。至少有21位MDACC教职员工是Swog的官方成员，并定期为几个swog委员会做出了积极贡献（例如，胃肠道，大脑，肺，H＆N和肉瘤委员会）。 Ei-Naggar博士将领导H＆N肿瘤生物学和相关科学小组委员会。 P. Pisters博士是Swog肉瘤标本板的顾问。至少有11位MDACC教师在17个swog协调的协调方案（包括3个开发方案）中作为研究协调员提供了科学领导，并共同撰写了18份Swog Papers（自2000年以来）。 MDACC将在swog环境中开发创新的第一阶段研究中运用其历史优势。第三阶段试验对于任何单个机构单独进行都是高度复杂的，并且很难单独进行，MDACC期待领导一些人，并加入其他Swog努力，以测试相关的，改善标准的改善标准试验。